Publication | Closed Access
Treatment of thrombotic microangiopathy after hematopoietic stem cell transplantation with recombinant human soluble thrombomodulin
33
Citations
25
References
2015
Year
This is the first report evaluating rTM administration for TA-TMA compared with previous treatments. Our data suggests that rTM might offer a better clinical outcome in patients with TA-TMA.
| Year | Citations | |
|---|---|---|
Page 1
Page 1